The former Global Head, Diagnostic Innovation and R&D and Clinical Biomarker Strategy and Development at Janssen, Johnson & Johnson
The former Vice President of R&D in Abbott's Molecular Diagnostic Division
The former Director of R&D for Novartis Vaccine and Drug Development, and the Executive Director at the Novartis Molecular Diagnostics and the Novartis Oncology Division for Drug and Companion Diagnostic co-development
The expert consultant of the Ministry of Science and Technology Council
The expert consultant of the Bio Taiwan Committee (BTC) under the Executive Yuan
The committee member of BTC since 2000
Min-Chun Chen, MD MPH
Currently Senior Staff Physician and Clinical Faculty in Internal Medicine and Hematology-Medical Oncology at MultiCare Regional Cancer Center affiliated with UW Med and Fred Hutchinson Cancer Center (FHCC)
Dr. Chen graduated from Taipei Medical College (TMC), now Taipei Medical University (TMU), in 1981; He studied at and obtained a MPH Degree from the University of Texas (UT) Health Sciences Center at Houston in 1984; He completed Internship and Residency Training in Internal Medicine at Cook County Hospital (now renamed John Stroger Jr Hospital), Chicago, IL, from 1984-1987, and Sub-Specialty Fellowship Training in Medical Oncology and Hematology at the University of Illinois School of Medicine at Chicago (UIC) from 1987-1990.
He returned to Taiwan in 1991, and practiced at VGH-Taichung, Koo Foundation Sun Yat-Sen Cancer Center, VGH-Taipei, and then, at National Taiwan University Hospital (NTUH) in Taipei as Clinical Investigator at the NTUH-Taiwan NIH Cancer Research Ward from 1996-1998.
Dr. Chen holds a Clinical Faculty position at University of Washington (UW) at Seattle, School of Medicine, Department of Medicine, Division of Medical Oncology since December 1, 2010, specialize in GENERAL MEDICAL ONCOLOGY and NON-MALIGNANT HEMATOLOGY. He has written and published more than 15 peer-reviewed journal articles and text-book chapters in the fields of Medical Oncology and Hematology from 1989 through 2017.